Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07466394) titled 'COGSCREEN II: Early Detection of Cognitive Impairment' on Feb. 25.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Screening. Masking: None (Open Label).

Primary Sponsor: Robert Perneczky

Condition: Alzheimer's Disease (AD)

Intervention: Behavioral: Early Detection

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: June 1, 2025

Target Sample Size: 400

Countries of Recruitment: Germany

To know more, visit https://clinicaltrials.gov/study/NCT07466394

Published by HT Digital Content Services with permission from...